Market revenue in 2023 | USD 41.8 million |
Market revenue in 2030 | USD 108.3 million |
Growth rate | 14.6% (CAGR from 2023 to 2030) |
Largest segment | Biorepository services |
Fastest growing segment | Biorepository Services |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Biorepository Services, Archiving Solution Services |
Key market players worldwide | Azenta Inc, Thermo Fisher Scientific Inc, Precision for Medicine, Medpace Holdings Inc, Labcorp Drug Development, ATCC, Q2 Solutions, LabConnect, Charles River Laboratories International Inc |
Biorepository services was the largest segment with a revenue share of 66.27% in 2023. Horizon Databook has segmented the India clinical trial biorepository & archiving solutions market based on biorepository services, archiving solution services covering the revenue growth of each sub-segment from 2018 to 2030.
Increasing number of clinical trials in India, owing to growing demand for treatment options for cardiovascular diseases, kidney diseases, and diabetes, is one of the major factors driving market growth. Therefore, to meet the growing demand, global market players are forming partnerships with various clinical trial outsourcing firms in India to expand their service offerings in the country.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account